We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
2651
West Pharmaceutical
WST
$24.8B
-3,675
Closed -$1.56M
WT icon
2652
WisdomTree
WT
$3.56B
-73,216
Closed -$415K
WVE icon
2653
Wave Life Sciences
WVE
$1.04B
-18,381
Closed -$90K
WW
2654
DELISTED
WW International
WW
-45,070
Closed -$823K
WWW icon
2655
Wolverine World Wide
WWW
$1.72B
-32,590
Closed -$972K
XAR icon
2656
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.19B
-2,885
Closed -$344K
XBI icon
2657
State Street SPDR S&P Biotech ETF
XBI
$11.2B
-50,593
Closed -$6.36M
XCUR icon
2658
Exicure
XCUR
$7.53M
-68
Closed -$12K
XENE icon
2659
Xenon Pharmaceuticals
XENE
$5.88B
-11,866
Closed -$181K
XLE icon
2660
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
-735,122
Closed -$19.1M
XLY icon
2661
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
-22,052
Closed -$1.98M
XOP icon
2662
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
-35,731
Closed -$3.46M
XP icon
2663
XP
XP
$8.53B
-58,212
Closed -$2.34M
XPO icon
2664
CALL
XPO
XPO
$23.2B
-4,208
Closed -$199K
XRAY icon
2665
Dentsply Sirona
XRAY
$2.18B
-18,414
Closed -$1.07M
XRX icon
2666
Xerox
XRX
$381M
-37,700
Closed -$760K
XXII
2667
22nd Century Group
XXII
$2.68M
0
-$133K
XWEL icon
2668
XWELL
XWEL
$8.93M
-2,234
Closed -$66K
YMAB
2669
DELISTED
Y-mAbs Therapeutics
YMAB
-17,399
Closed -$497K
YMM icon
2670
Full Truck Alliance
YMM
$9.1B
-50,978
Closed -$781K
GTM
2671
CALL
ZoomInfo Technologies
GTM
$1.16B
-60,000
Closed -$3.67M
GTM
2672
ZoomInfo Technologies
GTM
$1.16B
-393,795
Closed -$24.1M
ZLAB icon
2673
Zai Lab
ZLAB
$2.92B
-2,053
Closed -$216K
ZM icon
2674
CALL
Zoom
ZM
$31.5B
-11,400
Closed -$2.98M
ZS icon
2675
Zscaler
ZS
$29.4B
-43,686
Closed -$11.5M

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.